COMMUNIQUÉS West-GlobeNewswire

Publication relative à des notifications de transparence
27/02/2026
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 27 février 2026 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
27/02/2026
RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
27/02/2026
ZUG, Switzerland, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
27/02/2026
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate [...]
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
27/02/2026
TORONTO and HAIFA, Israel, Feb. 27, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biopharmaceutical company developing exosome-based [...]
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
27/02/2026
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before [...]
Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
27/02/2026
WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
27/02/2026
Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
27/02/2026
Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 587,495 restricted stock units to members of management and employees [...]
LeMaitre to Participate at Upcoming Investor Conferences in March
27/02/2026
BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March. Leerink Partners Global [...]
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
27/02/2026
WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) [...]
AshtonManual.org Launches as the Definitive Resource for Safe, Evidence-Based Benzodiazepine Tapering
27/02/2026
New Educational Platform Brings the Gold Standard of Benzodiazepine Withdrawal Guidance to Patients and Families, Backed by the Clinical Expertise of Dr. Mark Leeds, D.O. Fort Lauderdale, FL, Feb. 27, 2026 (GLOBE [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
27/02/2026
Strong cash position at year-end 2025: $33.3 million (€28.4 million) CNS (Vafidemstat) Appointed renowned Rolando Gutierrez-Esteinou, M.D. as new CMO for CNS Preparing protocol resubmission to incorporate FDA guidance [...]
Disclosure of a transparency notification from AOC Pharma S.à r.l.
27/02/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure [...]
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States
27/02/2026
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States Irving, Texas, USA – February 27, 2026 – Atos , a global leader in AI-powered digital transformation, today [...]
Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
27/02/2026
Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or dose-limiting toxicities at three months Early signals of functional and structural improvement [...]
The Standard Process Brand Evolution Elevates Awareness of Whole Food Nutrition
27/02/2026
The company’s 97-year commitment to restore nutritional integrity as the foundation of health A Media Snippet accompanying this announcement is available by clicking on this link. PALMYRA, Wis., Feb. 27, 2026 (GLOBE [...]
New Study Finds Half of Americans Don’t Know You Can Screen for Colorectal Cancer at Home
27/02/2026
Knowledge Gaps and Dismissed Symptoms May Contribute to Rising Deaths in Younger Adults WASHINGTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Colorectal cancer is now the leading cause of cancer-related death among adults under [...]
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
27/02/2026
After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to Achieve Near-term [...]

Pages